Gradient
1 FDA Guidance on Hemp Product Development
  • In Sep 2018, FDA approved Epidiolex (Cannabidiol) Primer, the first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication, to treat Dravet syndrome or Lennox-Gastaut syndrome.​

  • In Feb 2020, FDA issued an opinion to encourage cannabis companies to develop cannabis products to prescription drugs through botanical drug development guidance for industry.

  • In July 2020, FDA developed a draft GFI "Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry"​​

 

 
 
 
 

Philadelphia, USA | Blainville, Canada | Cambridge, UK | Semengoh, Malaysia | Hangzhou, China